SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Acquisition

5 Apr 2017 07:00

RNS Number : 5869B
Porvair PLC
05 April 2017
 



For immediate release 5 April 2017

 

 

Porvair plc

 

Acquisition

 

Porvair ("the Group"), the specialist filtration and environmental technologies group, announces the acquisition of J. G. Finneran Associates, Inc. ("JGF").  JGF, based in Vineland, New Jersey, designs, manufactures and distributes specialist laboratory consumables including filters, vials, microplates, closures and ancillary products.

On 4 April 2017, Porvair acquired 100% of the issued share capital of JGF and its related freehold property from the Finneran family ("the Acquisition").

The initial consideration for the Acquisition is $8.0m, payable in cash, with a further deferred cash payment of up to a maximum of $6.0m, payable in the years ending 30 November 2018 and 2019, subject to the satisfaction of certain growth targets during the years ending 31 March 2018 and 2019. The Acquisition is expected to be earnings enhancing in its first full year of ownership.

The Board sees a good fit between JGF and Porvair's already established life science and biotechnology activities. JGF brings manufacturing capabilities and strong US distribution to the Group. Together the businesses have a broad product offering for chromatography, sample preparation and environmental laboratories. Opportunities exist for combining manufacturing and marketing activities. 

The Board is pleased to welcome the Finneran family and JGF staff to the Porvair Group.

 

For further information, please contact:

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Stephanie Watson

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration and environmental technology businesses. Its products are used in a range of niche filtration markets, and are derived from its expertise in the design and manufacture of filtration systems using ceramic, metal, plastic and carbon media. Its Seal Analytical business is a market leader in the manufacture of laboratory based water analysis equipment.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (EU) No. 596/2014

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQOKQDBABKDKQK
Date   Source Headline
22nd May 20269:16 amRNSHolding(s) in Company
22nd May 20269:15 amRNSHolding(s) in Company
28th Apr 20267:00 amRNSAppointment of Joint Corporate Broker
24th Apr 20264:30 pmRNSHolding(s) in Company
24th Apr 202610:15 amRNSHolding(s) in Company
14th Apr 20264:29 pmRNSResults of AGM
14th Apr 20267:00 amRNSAGM Trading Update
1st Apr 20264:30 pmRNSTotal Voting Rights
26th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSNotice of AGM
11th Mar 20267:00 amRNSNotice of AGM
3rd Mar 202610:00 amRNSHolding(s) in Company
27th Feb 20263:00 pmRNSTotal Voting Rights
24th Feb 20265:45 pmRNSDirector/PDMR Shareholding
19th Feb 20261:00 pmRNSHolding(s) in Company
17th Feb 20262:00 pmRNSDirector/PDMR Shareholding
13th Feb 20264:15 pmRNSDirector/PDMR Shareholding
9th Feb 20263:45 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSFull Year Results
6th Feb 20264:00 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSHolding(s) in Company
30th Jan 202612:00 pmRNSTotal Voting Rights
26th Jan 202610:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSAcquisition of Drache Umwelttechnik GmbH
6th Jan 20267:00 amRNSBlock listing Return
17th Dec 202510:00 amRNSHolding(s) in Company
15th Dec 20257:00 amRNSYear end trading update and notice of results
11th Dec 20254:00 pmRNSHolding(s) in Company
5th Dec 20259:30 amRNSHolding(s) in Company
2nd Dec 202511:00 amRNSHolding(s) in Company
27th Oct 20257:00 amRNSTotal Voting Rights
7th Oct 20257:00 amRNSBlock Listing Return
25th Sep 20257:00 amRNSBoard Changes
16th Sep 20257:00 amRNSNine Month Trading Update
4th Sep 20257:30 amRNSHolding(s) in Company
23rd Jul 20255:30 pmRNSHolding(s) in Company
23rd Jul 20259:00 amRNSHolding(s) in Company
30th Jun 20257:00 amRNSInterim Results
19th Jun 202510:04 amRNSBlocklisting Application
17th Jun 20254:40 pmRNSHolding(s) in Company
29th May 202512:00 pmRNSHolding(s) in Company
28th Apr 20259:00 amRNSHolding(s) in Company
25th Apr 20259:00 amRNSHolding(s) in Company
17th Apr 20257:00 amRNSChange of Remuneration Committee Chair
15th Apr 20253:00 pmRNSHolding(s) in Company
15th Apr 20252:43 pmRNSAGM resolutions
15th Apr 20257:00 amRNSAGM Trading Update
9th Apr 202512:00 pmRNSBlock listing Interim Review
7th Apr 20258:00 amRNSDirector Declaration
4th Apr 202510:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.